179 related articles for article (PubMed ID: 29194460)
1. Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.
Koparde V; Abdul Razzaq B; Suntum T; Sabo R; Scalora A; Serrano M; Jameson-Lee M; Hall C; Kobulnicky D; Sheth N; Feltz J; Contaifer D; Wijesinghe D; Reed J; Roberts C; Qayyum R; Buck G; Neale M; Toor A
PLoS One; 2017; 12(12):e0187771. PubMed ID: 29194460
[TBL] [Abstract][Full Text] [Related]
2. Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.
Abdul Razzaq B; Scalora A; Koparde VN; Meier J; Mahmood M; Salman S; Jameson-Lee M; Serrano MG; Sheth N; Voelkner M; Kobulnicky DJ; Roberts CH; Ferreira-Gonzalez A; Manjili MH; Buck GA; Neale MC; Toor AA
Biol Blood Marrow Transplant; 2016 May; 22(5):850-61. PubMed ID: 26688192
[TBL] [Abstract][Full Text] [Related]
3. Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.
Hall CE; Koparde VN; Jameson-Lee M; Elnasseh AG; Scalora AF; Kobulnicky DJ; Serrano MG; Roberts CH; Buck GA; Neale MC; Nixon DE; Toor AA
PLoS One; 2017; 12(8):e0178763. PubMed ID: 28800601
[TBL] [Abstract][Full Text] [Related]
4. Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.
Salman A; Koparde V; Hall CE; Jameson-Lee M; Roberts C; Serrano M; AbdulRazzaq B; Meier J; Kennedy C; Manjili MH; Spellman SR; Wijesinghe D; Hashmi S; Buck G; Qayyum R; Neale M; Reed J; Toor AA
Front Immunol; 2018; 9():2284. PubMed ID: 30364159
[TBL] [Abstract][Full Text] [Related]
5. In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.
Jameson-Lee M; Koparde V; Griffith P; Scalora AF; Sampson JK; Khalid H; Sheth NU; Batalo M; Serrano MG; Roberts CH; Hess ML; Buck GA; Neale MC; Manjili MH; Toor AA
Front Immunol; 2014; 5():529. PubMed ID: 25414699
[TBL] [Abstract][Full Text] [Related]
6. Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Story CM; Wang T; Bhatt VR; Battiwalla M; Badawy SM; Kamoun M; Gragert L; Brown V; Baxter-Lowe LA; Marsh SGE; Gadalla SM; Schetelig J; Mytilineos J; Miklos D; Waller EK; Kuxhausen M; Spellman S; Lee S; Paczesny S; Lansford JL; Vincent BG; Riches ML; Armistead PM;
Transplant Cell Ther; 2021 Jul; 27(7):591-599. PubMed ID: 33882342
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation.
Sampson JK; Sheth NU; Koparde VN; Scalora AF; Serrano MG; Lee V; Roberts CH; Jameson-Lee M; Ferreira-Gonzalez A; Manjili MH; Buck GA; Neale MC; Toor AA
Br J Haematol; 2014 Aug; 166(4):566-70. PubMed ID: 24749631
[TBL] [Abstract][Full Text] [Related]
9. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. New developments in allotransplant immunology.
Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N
Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical transplantation for hematologic malignancies: where do we stand?
Fuchs EJ
Hematology Am Soc Hematol Educ Program; 2012; 2012():230-6. PubMed ID: 23233586
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.
Kumar P; Defor TE; Brunstein C; Barker JN; Wagner JE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1394-400. PubMed ID: 19041062
[TBL] [Abstract][Full Text] [Related]
15. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
16. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
[TBL] [Abstract][Full Text] [Related]
17. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
18. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
[TBL] [Abstract][Full Text] [Related]
19. Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Ho VT; Kim HT; Aldridge J; Liney D; Kao G; Armand P; Koreth J; Cutler C; Ritz J; Antin JH; Soiffer RJ; Alyea EP
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1196-204. PubMed ID: 21193054
[TBL] [Abstract][Full Text] [Related]
20. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.
Alyea EP; Weller E; Fisher DC; Freedman AS; Gribben JG; Lee S; Schlossman RL; Stone RM; Friedberg J; DeAngelo D; Liney D; Windawi S; Ng A; Mauch P; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2002; 8(11):601-7. PubMed ID: 12463479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
